MRNA a medical Technology Stock LONG
Güncellendi
MRNA is a medical technology company. It is in the vaccine sector and competes ( well) with
NVAX and PFE among others. Earnings are upcoming on 8/3 in about a week.
On the 30 minute chart it appears to be in a descending wedge pattern which is typically
a bottoming with a breakout over and beyond the descending trendline. The relative
trend indicator shows the downtrend to be a slow grinding type trend with some minor
corrections along the way. As might be expected the RS lines are low in the indicator's
channel. I see this as a setup for a pre-earnings play with the expectation that MRNA
could breakout above the resistance trend line and move toward the horizontal resistance
of the triple top earlier in mid-July. I see medical stocks as a good alternative to technology
stocks that may be overextended and stressed by the current financial chaos pressuring
the markets. Another approach is a two call options targeting $ 125 expiring 8/11
and running the first until 100% profit or 8/2, the day before the expiration whichever
comes first and letting the other run through earnings into the middle of the following
week at 8/9. I always like to cut these short of expiration by a few days to diminish the
effects of time decay.
NVAX and PFE among others. Earnings are upcoming on 8/3 in about a week.
On the 30 minute chart it appears to be in a descending wedge pattern which is typically
a bottoming with a breakout over and beyond the descending trendline. The relative
trend indicator shows the downtrend to be a slow grinding type trend with some minor
corrections along the way. As might be expected the RS lines are low in the indicator's
channel. I see this as a setup for a pre-earnings play with the expectation that MRNA
could breakout above the resistance trend line and move toward the horizontal resistance
of the triple top earlier in mid-July. I see medical stocks as a good alternative to technology
stocks that may be overextended and stressed by the current financial chaos pressuring
the markets. Another approach is a two call options targeting $ 125 expiring 8/11
and running the first until 100% profit or 8/2, the day before the expiration whichever
comes first and letting the other run through earnings into the middle of the following
week at 8/9. I always like to cut these short of expiration by a few days to diminish the
effects of time decay.
İşlem aktif
The stock shares purchased at the premarket open have moved; price is now approaching the upper resistance trendline of the descending wedge. So far so good.İşlem aktif
Price breaking out. Stop loss raised to above break-even. Awaiting regular sessionfor purchase of the two call options.
Feragatname
Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, işlem veya diğer türden tavsiye veya tavsiyeler anlamına gelmez ve teşkil etmez. Kullanım Şartları'nda daha fazlasını okuyun.